According to Eterna Therapeutics's latest financial reports and stock price the company's current number of shares outstanding is 5,410,000. At the end of 2023 the company had 5,410,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 5.41 M | 48.99% |
2022 | 3.63 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Sanofi SNY | 2,507,200,000 | 46,243.81% | ๐ซ๐ท France |
Baxter BAX | 507,000,000 | 9,271.53% | ๐บ๐ธ USA |
Omeros Corporation OMER | 62,856,721 | 1,061.86% | ๐บ๐ธ USA |
Geron GERN | 594,977,503 | 10,897.74% | ๐บ๐ธ USA |
Genetic Technologies GENE | 129,424 | -97.61% | ๐ฆ๐บ Australia |
Teva Pharmaceutical Industries TEVA | 1,121,000,000 | 20,620.89% | ๐ฎ๐ฑ Israel |
Bio-Techne TECH | 157,533,000 | 2,811.89% | ๐บ๐ธ USA |